obesity treatment with bariatric surgery vs glp-1 receptor agonists Weight Loss vs. Medication: What's Better? Cost effectiveness of GLP-1 s
Description
BMC Endocr Disord 2023

doi: 10.1152/ajpendo.00446.2012 [DOI] [PubMed] [Google Scholar] 38

Ji, L., Dong, X., Li, Y., Li, Y., Lim, S., Liu, M., Ning, Z., Rasmussen, S., Skjth, T

DPP-4 inhibitors must not be used concurrently with GLP-1 receptor agonists Sulfonylureas (e.g., gliclazide) can achieve comparable or greater HbA1c reductions but carry a higher risk of hypoglycaemia and weight gain

Neural contribution to the effect of glucagon-like peptide-1-(7-36) amide on arterial blood pressure in rats
